Sectra AB (publ) (SECT-B.ST)
SEK 274.3
(0.94%)
SEK 274.3
(0.94%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 19.2 Million SEK | -66.29% |
| 2022 | 56.96 Million SEK | 50.34% |
| 2021 | 37.89 Million SEK | -21.13% |
| 2020 | 48.04 Million SEK | -21.89% |
| 2019 | 61.51 Million SEK | 853.53% |
| 2018 | 6.45 Million SEK | -77.39% |
| 2017 | 28.52 Million SEK | -49.61% |
| 2016 | 56.61 Million SEK | 7.7% |
| 2015 | 52.56 Million SEK | 11.98% |
| 2014 | 46.94 Million SEK | 25.52% |
| 2013 | 37.39 Million SEK | 41.1% |
| 2012 | 26.5 Million SEK | 53.55% |
| 2011 | 17.26 Million SEK | 0.0% |
| 2010 | - SEK | 0.0% |
| 2009 | - SEK | -100.0% |
| 2008 | 95 Thousand SEK | -15.18% |
| 2007 | 112 Thousand SEK | 0.0% |
| 2006 | - SEK | 0.0% |
| 2005 | - SEK | -100.0% |
| 2004 | 13.87 Million SEK | -65.28% |
| 2003 | 39.95 Million SEK | 39.94% |
| 2002 | 28.55 Million SEK | 25.65% |
| 2001 | 22.72 Million SEK | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 32.81 Million SEK | 0.0% |
| 2023 Q1 | 52.13 Million SEK | -8.48% |
| 2023 Q4 | 19.2 Million SEK | 63.55% |
| 2023 Q3 | 11.74 Million SEK | -28.03% |
| 2023 Q2 | 16.31 Million SEK | -68.71% |
| 2023 FY | 19.2 Million SEK | -66.29% |
| 2022 Q3 | 55.87 Million SEK | 88.47% |
| 2022 FY | 56.96 Million SEK | 50.34% |
| 2022 Q2 | 29.64 Million SEK | -11.7% |
| 2022 Q1 | 33.57 Million SEK | -11.39% |
| 2022 Q4 | 56.96 Million SEK | 1.95% |
| 2021 Q1 | 46.03 Million SEK | -4.18% |
| 2021 Q2 | 43.99 Million SEK | -4.43% |
| 2021 Q3 | 41.98 Million SEK | -4.57% |
| 2021 Q4 | 37.89 Million SEK | -9.75% |
| 2021 FY | 37.89 Million SEK | -21.13% |
| 2020 FY | 48.04 Million SEK | -21.89% |
| 2020 Q1 | 53.6 Million SEK | -12.86% |
| 2020 Q3 | 51.14 Million SEK | -12.71% |
| 2020 Q2 | 58.58 Million SEK | 9.3% |
| 2020 Q4 | 48.04 Million SEK | -6.05% |
| 2019 Q3 | 2.95 Million SEK | -95.03% |
| 2019 Q2 | 59.43 Million SEK | -7.3% |
| 2019 Q1 | 64.11 Million SEK | 893.89% |
| 2019 FY | 61.51 Million SEK | 853.53% |
| 2019 Q4 | 61.51 Million SEK | 1984.45% |
| 2018 Q1 | 28.52 Million SEK | 0.0% |
| 2018 Q3 | 6.45 Million SEK | -78.05% |
| 2018 Q4 | 6.45 Million SEK | 0.0% |
| 2018 FY | 6.45 Million SEK | -77.39% |
| 2018 Q2 | 29.38 Million SEK | 3.01% |
| 2017 Q1 | 56.61 Million SEK | 0.0% |
| 2017 FY | 28.52 Million SEK | -49.61% |
| 2017 Q3 | 28.52 Million SEK | -49.61% |
| 2017 Q2 | 56.61 Million SEK | 0.0% |
| 2017 Q4 | 28.52 Million SEK | 0.0% |
| 2016 Q1 | 50.09 Million SEK | -4.7% |
| 2016 FY | 56.61 Million SEK | 7.7% |
| 2016 Q3 | 56.61 Million SEK | 13.01% |
| 2016 Q2 | 50.09 Million SEK | 0.0% |
| 2016 Q4 | 56.61 Million SEK | 0.0% |
| 2015 Q3 | 52.56 Million SEK | 38.45% |
| 2015 Q2 | 37.96 Million SEK | 0.0% |
| 2015 Q1 | 37.96 Million SEK | -19.12% |
| 2015 Q4 | 52.56 Million SEK | 0.0% |
| 2015 FY | 52.56 Million SEK | 11.98% |
| 2014 Q4 | 46.94 Million SEK | 0.0% |
| 2014 Q3 | 46.94 Million SEK | 65.12% |
| 2014 Q2 | 28.42 Million SEK | 0.0% |
| 2014 Q1 | 28.42 Million SEK | -23.98% |
| 2014 FY | 46.94 Million SEK | 25.52% |
| 2013 Q4 | 37.39 Million SEK | 0.0% |
| 2013 Q1 | 20.41 Million SEK | -22.98% |
| 2013 Q2 | 27.17 Million SEK | 33.12% |
| 2013 Q3 | 37.39 Million SEK | 37.63% |
| 2013 FY | 37.39 Million SEK | 41.1% |
| 2012 Q1 | - SEK | -100.0% |
| 2012 Q3 | 26.5 Million SEK | 29.6% |
| 2012 Q4 | 26.5 Million SEK | 0.0% |
| 2012 FY | 26.5 Million SEK | 53.55% |
| 2012 Q2 | 20.45 Million SEK | 0.0% |
| 2011 Q2 | - SEK | -100.0% |
| 2011 Q1 | 6.09 Million SEK | 0.0% |
| 2011 FY | 17.26 Million SEK | 0.0% |
| 2011 Q4 | 17.26 Million SEK | 0.0% |
| 2011 Q3 | 17.26 Million SEK | 0.0% |
| 2010 Q4 | - SEK | 0.0% |
| 2010 FY | - SEK | 0.0% |
| 2010 Q3 | - SEK | 0.0% |
| 2010 Q1 | - SEK | 0.0% |
| 2010 Q2 | - SEK | 0.0% |
| 2009 Q4 | - SEK | 0.0% |
| 2009 FY | - SEK | -100.0% |
| 2008 FY | 95 Thousand SEK | -15.18% |
| 2007 FY | 112 Thousand SEK | 0.0% |
| 2006 FY | - SEK | 0.0% |
| 2005 FY | - SEK | -100.0% |
| 2004 FY | 13.87 Million SEK | -65.28% |
| 2003 FY | 39.95 Million SEK | 39.94% |
| 2002 FY | 28.55 Million SEK | 25.65% |
| 2001 FY | 22.72 Million SEK | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 98.682% |
| ADDvise Group AB (publ) | 1.45 Billion SEK | 98.682% |
| Arcoma AB | 1.92 Million SEK | -896.575% |
| Bactiguard Holding AB (publ) | 42.3 Million SEK | 54.607% |
| BICO Group AB (publ) | 1.75 Billion SEK | 98.906% |
| Boule Diagnostics AB (publ) | 57.7 Million SEK | 66.718% |
| CellaVision AB (publ) | 28.66 Million SEK | 33.003% |
| Clinical Laserthermia Systems AB (publ) | 223 Thousand SEK | -8511.659% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.75 Million SEK | -995.493% |
| Duearity AB (publ) | 2.94 Million SEK | -553.197% |
| Dignitana AB (publ) | 6.07 Million SEK | -216.011% |
| Episurf Medical AB (publ) | 2.3 Million SEK | -734.957% |
| Getinge AB (publ) | 3.9 Billion SEK | 99.508% |
| Scandinavian Real Heart AB (Publ) | 6.35 Million SEK | -202.286% |
| Iconovo AB (publ) | 4.9 Million SEK | -291.367% |
| Integrum AB (publ) | 4.84 Million SEK | -296.404% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -9221.244% |
| Mentice AB (publ) | 2.14 Million SEK | -795.709% |
| OssDsign AB (publ) | 214 Thousand SEK | -8873.832% |
| Paxman AB (publ) | 2.53 Million SEK | -658.452% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 3 Million SEK | -539.281% |
| SciBase Holding AB (publ) | 4.17 Million SEK | -359.536% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sedana Medical AB (publ) | 1.01 Million SEK | -1797.628% |
| Senzime AB (publ) | 8.57 Million SEK | -123.875% |
| SpectraCure AB (publ) | 4.39 Million SEK | -336.752% |
| Stille AB | 38.06 Million SEK | 49.551% |
| Vitrolife AB (publ) | 1.87 Billion SEK | 98.976% |
| Xvivo Perfusion AB (publ) | 21.16 Million SEK | 9.282% |